Elizabeth Anne Belloli
Ambulatory Care Clinical Chief
Clinical Associate Professor of Internal Medicine
Pulmonary & Critical Care Medicine
3916 Taubman Center, 1500 E. Medical Center Dr.
Ann Arbor, MI 48109-5360
[email protected]

Available to mentor
Elizabeth Anne Belloli
Clinical Associate Professor
  • Qualifications
  • Recent Publications
    • Qualifications
    • MD
      University of Michigan, 1500 Medical Center Drive, 2009
    • BA
      University of Michigan, Ann Arbor, 2004
    Recent Publications See All Publications
    • Journal Article
      Acute exacerbations in patients with progressive pulmonary fibrosis
      Kreuter M, Belloli EA, Bendstrup E, Cerri S, Flaherty KR, Shapera S, Song JW, Mueller H, Rohr KB, Kondoh Y. ERJ Open Research, 00403 - 02024. DOI:10.1183/23120541.00403-2024
    • Journal Article
      Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).
      Combs MP, Belloli EA, Gargurevich N, Flaherty KR, Murray S, Galbán CJ, Lama VN. J Heart Lung Transplant, 2024 Sep; 43 (9): 1468 - 1477. DOI:10.1016/j.healun.2024.05.013
      PMID: 38796045
    • Journal Article
      Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.
      Raghu G, Richeldi L, Fernández Pérez ER, De Salvo MC, Silva RS, Song JW, Ogura T, Xu ZJ, Belloli EA, Zhang X, Seid LL, Poole L, ZEPHYRUS-1 Study Investigators . JAMA, 2024 Aug 6; 332 (5): 380 - 389. DOI:10.1001/jama.2024.8693
      PMID: 38762797
    • Proceeding / Abstract / Poster
      Pamrevlumab for Idiopathic Pulmonary Fibrosis: Results of the Phase 3 Zephyrus-1 Study
      Raghu G, Richeldi L, Fernández Pérez ER, De Salvo MC, Silva RS, Song JW, Ogura T, Xu Z, Belloli EA, Zhang X, Seid LL, Poole L. 2024 May; a6613 - a6613. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6613
    • Proceeding / Abstract / Poster
      Reducing Short Acting Beta2 Agonist (SABA) Prescription Refills in Specialist Treated Asthma: A Quality Improvement Initiative
      Mohan A, Spranger E, Cox A, Guzman R, Farhat N, Kovalszki A, Lewis TC, Langlois D, Hudson R, Fan A, Belloli E, Wright-Nunes J, Sagana RL, Lugogo NL. 2024 May; a7011 - a7011. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7011
    • Proceeding / Abstract / Poster
      Safety and Tolerability of SGLT-2 Inhibitors Following Lung Transplantation
      Wilcox P, Walter K, Troost J, Belloli E. 2024 May; a3724 - a3724. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3724
    • Proceeding / Abstract / Poster
      (1018) Incidence and Risk Factors of Venous Thromboembolism in Lung Transplant Recipients
      Walter K, Combs M, Belloli E, Lyu D. The Journal of Heart and Lung Transplantation, 2024 Apr; 43 (4): s475 - s475. DOI:10.1016/j.healun.2024.02.635
    • Proceeding / Abstract / Poster
      Evaluation of Use of Tacrolimus vs. Cyclosporine on CLAD Incidence and Allograft Survival in the ISHLT Registry
      Combs MP, Walter K, Hixson H, Belloli EA, Chan KM, Chang AC, Lyu DM. The Journal of Heart and Lung Transplantation, 2024 Apr; 43 (4): s297 - s298. DOI:10.1016/j.healun.2024.02.427
    Featured News & Stories 36th Annual Update in Pulmonary & Critical Care Medicine
    Department News
    Update in Pulmonary & Critical Care Medicine CME Course
    Join us for the 36th Annual Update in Pulmonary & Critical Care Medicine taking place on Thursday, September 5 and Friday, September 6, 2024.